Lind Global Fund II LP 13D/13G Filings for Agile Therapeutics, Inc. (AGRX)

Lind Global Fund II LP 13D and 13G filings for Agile Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
4:33 pm
Purchase		 2022-12-31 13G Agile Therapeutics, Inc.
AGRX		 Lind Global Fund II LP 89,195
9.900%		 24,191increase
(+37.21%)		 Filing
2022-07-12
5:00 pm
Purchase		 2022-07-06 13G Agile Therapeutics, Inc.
AGRX		 Lind Global Fund II LP 65,004
9.900%		 65,004increase
(New Position)		 Filing